Latest impact factor announced for JBI Evidence Synthesis
Achieving Q1 in Health Care Sciences & Services
We are pleased to share that JBI Evidence Synthesis has received a Journal Impact Factor of 4.5.
The journal is placed in Quartile 1 (Q1) in the Health Care Sciences & Services category, with a Journal Impact Factor (JIF) percentile of 88.4.
JBI Evidence Synthesis has also achieved Q1 for the categories of General Nursing and General Medicine.
Associate Professor Aromataris, Editor-in-Chief, recognised the collective efforts of the many individuals behind this accomplishment. He extended his sincere thanks to both past and present members of the editorial office, the advisory board, the editorial panel, and the hundreds of volunteer peer reviewers whose dedication has been essential in upholding the journal’s high standards.
A/Prof Aromataris also thanked the authors:
“We're thrilled that the JBI Evidence Synthesis impact factor has risen to 4.5! Thank you to our editorial office, advisory board and editors – but most of all, thank you to our authors for 10+ years who have helped us establish a high-quality periodical."
JBI Evidence Synthesis is a multidisciplinary, peer-reviewed journal focused on disseminating rigorous, high-quality research that provides the best available evidence to inform healthcare policy and practice. It is the premier channel for diverse evidence syntheses that move beyond the inclusion of randomised controlled trials and experimental studies, providing the best available evidence. The journal publishes evidence synthesis methodology papers, diverse types of systematic reviews, and scoping reviews covering multidisciplinary healthcare topics. All publications follow JBI’s gold-standard, rigorous methodology and methods developed by JBI’s international scientific committee.
More Journal Metrics for JBI Evidence Synthesis are available on the journal’s website.